Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125448541 | 12544854 | 1 | I | 20160111 | 20160704 | 20160711 | 20160711 | EXP | FR-PFIZER INC-2016330007 | PFIZER | 59.00 | YR | M | Y | 0.00000 | 20160711 | OT | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125448541 | 12544854 | 1 | PS | NEURONTIN | GABAPENTIN | 1 | Oral | UNK, SINGLE | 20235 | ||||||||||
125448541 | 12544854 | 2 | SS | SKENAN | MORPHINE SULFATE | 1 | Oral | UNK, SINGLE | 0 | ||||||||||
125448541 | 12544854 | 3 | SS | SERESTA | OXAZEPAM | 1 | Oral | UNK SINGLE | 0 | TABLET | |||||||||
125448541 | 12544854 | 4 | SS | ZOPICLONE | ZOPICLONE | 1 | Oral | UNK SINGLE | 0 | ||||||||||
125448541 | 12544854 | 5 | C | EZETROL | EZETIMIBE | 1 | 0 | ||||||||||||
125448541 | 12544854 | 6 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 0 | ||||||||||||
125448541 | 12544854 | 7 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | 75 | 0 | |||||||||||
125448541 | 12544854 | 8 | C | LERCANIDIPINE | LERCANIDIPINE | 1 | 20 | 0 | |||||||||||
125448541 | 12544854 | 9 | C | BIPRETERAX /06377001/ | INDAPAMIDEPERINDOPRIL | 1 | 10 | 0 | |||||||||||
125448541 | 12544854 | 10 | C | EUPRESSYL /00631801/ | URAPIDIL | 1 | 60 | 0 | |||||||||||
125448541 | 12544854 | 11 | C | INSULATARD FLEXPEN | INSULIN HUMAN | 1 | 0 | ||||||||||||
125448541 | 12544854 | 12 | C | NOVORAPID | INSULIN ASPART | 1 | 0 | ||||||||||||
125448541 | 12544854 | 13 | C | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | 75 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125448541 | 12544854 | 1 | Toxicity to various agents |
125448541 | 12544854 | 2 | Toxicity to various agents |
125448541 | 12544854 | 3 | Toxicity to various agents |
125448541 | 12544854 | 4 | Toxicity to various agents |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125448541 | 12544854 | OT |
125448541 | 12544854 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125448541 | 12544854 | Chest pain | |
125448541 | 12544854 | Confusional state | |
125448541 | 12544854 | Depressed level of consciousness | |
125448541 | 12544854 | Malaise | |
125448541 | 12544854 | Pneumonia aspiration | |
125448541 | 12544854 | Presyncope | |
125448541 | 12544854 | Productive cough | |
125448541 | 12544854 | Road traffic accident | |
125448541 | 12544854 | Somnolence | |
125448541 | 12544854 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125448541 | 12544854 | 1 | 20160111 | 20160111 | 0 | |
125448541 | 12544854 | 2 | 20160111 | 20160111 | 0 | |
125448541 | 12544854 | 3 | 20160111 | 20160111 | 0 | |
125448541 | 12544854 | 4 | 20160111 | 20160111 | 0 |